Literature DB >> 35501554

Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Recent Advances and Future Directions in Translational Research.

Wengui Yu1.   

Abstract

Entities:  

Year:  2022        PMID: 35501554     DOI: 10.1007/s12975-022-01028-1

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  10 in total

1.  Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.

Authors:  R Loch Macdonald; Randall T Higashida; Emanuela Keller; Stephan A Mayer; Andy Molyneux; Andreas Raabe; Peter Vajkoczy; Isabel Wanke; Doris Bach; Aline Frey; Pegah Nowbakht; Sébastien Roux; Neal Kassell
Journal:  Stroke       Date:  2012-03-08       Impact factor: 7.914

2.  Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Andrew P Carlson; Daniel Hänggi; George K Wong; Nima Etminan; Stephan A Mayer; François Aldrich; Michael N Diringer; Erich Schmutzhard; Herbert J Faleck; David Ng; Benjamin R Saville; Thomas Bleck; Robert Grubb; Michael Miller; Jose I Suarez; Howard M Proskin; R Loch Macdonald
Journal:  Stroke       Date:  2020-03-06       Impact factor: 7.914

3.  Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

Authors:  R Loch Macdonald; Randall T Higashida; Emanuela Keller; Stephan A Mayer; Andy Molyneux; Andreas Raabe; Peter Vajkoczy; Isabel Wanke; Doris Bach; Aline Frey; Angelina Marr; Sébastien Roux; Neal Kassell
Journal:  Lancet Neurol       Date:  2011-06-02       Impact factor: 44.182

4.  Tenecteplase Thrombolysis for Acute Ischemic Stroke.

Authors:  Steven J Warach; Adrienne N Dula; Truman J Milling
Journal:  Stroke       Date:  2020-10-13       Impact factor: 7.914

5.  Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.

Authors:  Audrey A Grossen; Griffin L Ernst; Andrew M Bauer
Journal:  Neurosurg Focus       Date:  2022-03       Impact factor: 4.047

6.  Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.

Authors:  Sanne M Dorhout Mees; Ale Algra; W Peter Vandertop; Fop van Kooten; Hans A J M Kuijsten; Jelis Boiten; Robert J van Oostenbrugge; Rustam Al-Shahi Salman; Pablo M Lavados; Gabriel J E Rinkel; Walter M van den Bergh
Journal:  Lancet       Date:  2012-05-25       Impact factor: 79.321

Review 7.  Aneurysmal Subarachnoid Hemorrhage: the Last Decade.

Authors:  Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2020-10-19       Impact factor: 6.829

8.  Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.

Authors:  Peter J Kirkpatrick; Carole L Turner; Christopher Smith; Peter J Hutchinson; Gordon D Murray
Journal:  Lancet Neurol       Date:  2014-05-15       Impact factor: 44.182

Review 9.  Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review.

Authors:  William S Dodd; Dimitri Laurent; Aaron S Dumont; David M Hasan; Pascal M Jabbour; Robert M Starke; Koji Hosaka; Adam J Polifka; Brian L Hoh; Nohra Chalouhi
Journal:  J Am Heart Assoc       Date:  2021-07-30       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.